NL-OMON37939CompletedNot Applicable
Autologous conditioned plasma injection for acute hamstring muscle injury. - Dutch Hamstring Injection Therapy (HIT) study
Arthrex Medizinische Instrumente GmbH0 sites80 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •1.Clinical diagnosis of an acute hamstring injury, defined as:
- •- anamnestic acute injury
- •- anamnestic pain in posterior thigh
- •- localised pain during palpation of hamstring muscle
- •- localised pain during passive straight leg raising
- •- increasing pain during isometric contraction
- •2.Hamstring lesion proven on MRI (increased signal in injured muscle on T2 and/or STIR)
- •3. First injection will be performed maximal 5 days after injury
- •4. Informed consent
- •5. Age 18-50 year
Exclusion Criteria
- •1.Patient is not capable of doing an active exercise program
- •2.Patient has recieved injection therapy for this injury before
- •3. Patient does not have the intention to return to full sports activity
- •4.Patient does not want to recieve one of the two therapies
- •5.Cause of hamstring injury is an extrinsic trauma on posterior thigh
- •6.Patient has chronic low back pain
- •7.There are contraindications for MRI:pacemaker, pregnancy, claustrofobia
- •8.Patient has chronich hamstring complaints (> 2 months)
- •9.There is a grade 3 lesion (total rupture) on MRI
Investigators
Similar Trials
Completed
Not Applicable
Dutch Hamstring Injection Therapy study.Acute hamstring injuryAcute hamstringblessureAutologous Conditioned Plasma (ACP)Growth factorsNL-OMON23513The Hague Medical Centre AntoniushoveUniversity Medical Centre UtrechtSports Medical Centre of the Royal Dutch Football AssociationKNVB Sportmedisch CentrumWoudenbergseweg 563707 HX Zeisttelnr: 0343 499285/49915080
Not yet recruiting
Not Applicable
Autologous whole blood injection as treatment for Covid-19 infectioCTRI/2020/09/027904Dr M Christopher
Completed
Not Applicable
MyEloma Renal Impairment Trial: adjunctive plasma exchange in patients with newly diagnosed multiple myeloma and acute renal failureCancerISRCTN37161699Imperial College London (UK)280
Completed
Not Applicable
Efficacy of autologous plasma therapy on clinical symptoms of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria.Other urticaria (Urticaria: chronic, recurrent periodic)IRCT2016040627260N1Vice-chancellor for Research of Bushehr University of Medical Sciences30
Active, not recruiting
Phase 2
se of plasma of cured person to treat patient with severe covid-19Coronavirus infection, transfusion, C23, A00-B99, Coronavirus OC43, Human.A00-B99RBR-7f4mt9fHemocentro de Ribeirão Preto